Kai Yang

16PUBLICATIONS
21CO-AUTHORS
Cell physiologyPacific Peoples theory of change models for healthHaematological tumoursMicroelectromechanical systems (MEMS)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 14, 2026
Integrated Single-Cell Atlas Reveals Cross-Subtype Heterogeneity in Human Pulmonary Hypertension.

|Feb 03, 2026
Echinatin Alleviates Experimental Pulmonary Hypertension by PPARγ Pathway Activation.

Wei Feng, Dan Bai, Shaocong Mo

|Jun 06, 2025
Deficient FANCL Predisposes to Endothelial Damage: A New Therapeutic Target for Pulmonary Hypertension.

Shiyun Liu, Xiaoqian Shan, Yufei Sun

|Jan 06, 2025
Deficiency of Endothelial Piezo2 Impairs Pulmonary Vascular Angiogenesis and Predisposes Pulmonary Hypertension.

Feng Wei, Ziying Lin, Wenju Lu

|Dec 31, 2024
Oral administration of pioglitazone inhibits pulmonary hypertension by regulating the gut microbiome and plasma metabolome in male rats.

Zizhou Zhang, Yaru Liang, Shaocong Mo

|Dec 09, 2024
Letter by Huang et al Regarding Article, "Atherosclerosis Is a Smooth Muscle Cell-Driven Tumor-Like Disease".

Huixin Huang, Xuqi Yang, Kai Yang

Pageof 3

Frequent Collaborators

10 joint publications

Jian Wang

3 joint publications

Wenju Lu

3 joint publications

Huazhuo Feng

2 joint publications

Shaocong Mo